Study S002152

Pilot Study of Extended-release Exenatide to Improve Glucose Control and Reduce Systemic Inflammation in Diabetic, HIV-infected Adults on Antiretroviral Therapy

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01791465
Study type: INTERVENTIONAL
Phase: PHASE4
Masking: NONE
Status: TERMINATED
Enrollment: 6
Start: 2013-03
Primary completion: 2014-12
Lead sponsor: Vanderbilt University
Conditions: Human Immunodeficiency Virus Infection; Diabetes Mellitus
Interventions: DRUG:extended-release exenatide
Results posted: TRUE
Individual participant data sharing: NO
Secondary identifiers: NIH:P30AI054999

Registered primary outcomes

Serum Highly-sensitive C-reactive Protein (hsCRP) Levels at Baseline and 16 Weeks [baseline and 16 weeks]
Serum Interleukin 6 (IL-6) at Levels at Baseline and 16 Weeks [baseline and 16 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.